In humans, similarly to HIV-1, CCR5-Δ32 carriers also have a decreased likelihood of contracting hepatitis B virus [206], but these carriers improved outcomes during hepatitis C virus infection [207] and tick-borne encephalitis virus infections (TBEV) [208]. The gene discussed is CCR5; the disease is hepatitis C virus infection.